Page 7 of lupin

Lupin stock rating ‘Accumulate’: 13% upside seen on gSpiriva launch, US market gains; check target price

Elara Capital has set a target price of Rs 992 on Lupin stock, which is an upside of 13%, with…

Updated: June 22, 2023 17:07 IST

Lupin, Lupin Limited, HIV/AIDS, drugs, generic drugs, healthcare news, pharma news,

USFDA gives nod to Lupin’s inhaler for treatment of COPD

Tiotropium Bromide Inhalation Powder (RLD Spiriva) had estimated annual sales of USD 1,264 million in the U.S. (IQVIA MAT Mar…

June 21, 2023 13:57 IST

Lupin, Lupin Limited, Vizag, EIR, healthcare news, pharma news,

Lupin gets EIR from USFDA for its API Manufacturing Facility in Vizag

According to the press statement, the EIR was issued post the last inspection of the facility conducted from March 6…

June 19, 2023 15:36 IST

Lupin launches injection for treating Vitamin B1 Deficiency in the United States

According to IQVIA MAT April 2023, Thiamine Hydrochloride Injection USP had estimated annual sales of USD 35 million in the…

June 19, 2023 11:17 IST

healthcare revolution, health news, pharma news,

Lupin Diagnostics launches Satellite Laboratory in Vijayawada

Lupin Diagnostics also stated that four of Lupin’s laboratories have already attained NABL accreditation.

May 25, 2023 16:10 IST

Market awaits Lupin’s new product launch

Company anticipates Ebitda margin boost from gSpiriva in August.

May 16, 2023 01:35 IST

Lupin reports Q4FY23 profit at Rs 235.9 crore, revenue up 14% at Rs 4,430 crore; 200% dividend announced

Lupin posted revenue from operations at Rs 4,430.08 crore, up 14.1 per cent from Rs 3,883.03 crore in the fourth…

May 10, 2023 11:26 IST

Lupin Diagnostics launches Regional Reference Laboratory in Bengaluru

Lupin Diagnostics leverages automation and streamlined processes to deliver highly accurate test results, empowering patients to make informed decisions about…

April 12, 2023 16:18 IST

Rating: buy; Lupin’s current US sales to suffer

Faces $20 million revenue risk as Indore Unit 2 resolution delayed

April 4, 2023 04:10 IST

USFDA approves Lupin’s tablets for Hepatitis B infection treatment

Tenofovir Alafenamide Tablets, 25 mg, (RLD Vemlidy) had estimated annual sales of USD 531 million in the U.S. (IQVIA MAT…

March 31, 2023 15:25 IST

CDSCO, drug alert, DCGI, spurious drugs, drug quality, healthcare news, pharma news

Rating: buy; Lupin to focus more on speciality segment for future growth

Material improvement in Ebitda to be driven by topline growth

February 28, 2023 02:00 IST

Lupin launches generic tablets for mental disorders in United States

Lurasidone Hydrochloride Tablets, 20 mg, 40 mg, 60 mg, 80 mg and 120 mg (RLD Latuda) had estimated annual sales…

February 21, 2023 14:46 IST

Lupin reports decline in profit by 72 percent to Rs. 153 crore in Q3FY23

The consolidated revenue advanced albeit marginally by 3.9 percent year-on-year (YoY) to Rs 4,322 crore in Q3FY23.

February 10, 2023 15:25 IST

USFDA tentatively approves Lupin’s HIV/AIDS tablets

The tentative approval has been granted under the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR).

January 31, 2023 14:25 IST

Lupin, Lupin Digital Health, Lupin Limited, Healthcare news, pharma news,

Lupin launches its digital therapeutics solution for cardiac care

The company claims that LYFE offers expert intervention in the form of dedicated care managers, health coaches and nutritionists.

January 24, 2023 17:29 IST

Drug Prices, Diabetes, Anxiety, NPPA, healthcare news, pharma news,

Lupin launches generic version of Novartis’ heart failure drug in India

Studies show that in India, Heart Failure remains one of the most prevalent causes of death in patients suffering from…

January 18, 2023 18:42 IST

USFDA tentatively approves Lupin’s two HIV/AIDS tablets

Dolutegravir and Rilpivirine Tablets, 50 mg/25 mg, (RLD Juluca) had estimated annual sales of USD 666 million in the U.S.…

January 16, 2023 14:52 IST

USFDA approves Lupin’s generic heart disorder tablets

Prasugrel Tablets USP, 5 mg and 10 mg, (RLD Effient) had estimated annual sales of USD 18 million in the…

January 10, 2023 17:08 IST

Related News

Aadhaar Card update October 2025: Here’s how to change name, address, date of birth and phone number online in simple steps

What is SB 509? Controversial ‘anti-India’ bill vetoed by California Gov Newsom

US visa rules, US visa policy, immigrant visa interview, nonimmigrant visa update, consular district interview, US embassy visa process, visa scheduling changes 2025, US travel regulations

US announces stricter visa interview rules for all immigrant and nonimmigrant applicants

Who is Alexandr Wang? The 28-year-old hired by Mark Zuckerberg for $14 billion to head Meta’s Superintelligence Labs

US Supreme Court won't review rule allowing H-1B holders' spouses to work

Big relief for spouses of H-1B visa holders as US Supreme Court rejects challenge to H-4 work rule

Room opened for rate cut, time not opportune: RBI Guv

Policy6 hr ago

RBI governor Sanjay Malhotra believes that although there is room for a repo rate cut, the current external uncertainties and ongoing transmission of previous measures make the timing unsuitable. The MPC decided to maintain a pause, but acknowledged India’s strong economy.

View all shorts